Phase II Study of Abiraterone Acetate and Prednisone in Combination With Cabazitaxel, Compared to Cabazitaxel Alone, in Patients With Metastatic Castrate Resistant Prostate Cancer.
Phase of Trial: Phase II
Latest Information Update: 06 Jun 2018
At a glance
- Drugs Abiraterone acetate (Primary) ; Cabazitaxel (Primary) ; Prednisone
- Indications Adenocarcinoma; Prostate cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 31 May 2018 Status changed from completed to discontinued.
- 06 Mar 2017 Status changed from active, no longer recruiting to completed.